Stay updated on Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T03:16:49.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include new identifiers for a clinical trial related to Chronic Lymphocytic Leukemia, while significant details about the study's design and inclusion/exclusion criteria have been removed.
    Difference
    12%
    Check dated 2025-04-16T14:21:40.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and changed the date from 2025-03-25 to 2025-02-03.
    Difference
    0.2%
    Check dated 2025-04-09T09:14:01.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 3, 2025, and version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-01T23:17:22.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T13:49:39.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-18T08:52:23.000Z thumbnail image

Stay in the know with updates to Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.